Aprea Therapeutics GAAP EPS of -$0.47, revenue of $1.84M

Published 4 hours ago Neutral
Aprea Therapeutics GAAP EPS of -$0.47, revenue of $1.84M
Auto
* Aprea Therapeutics press release [https://seekingalpha.com/pr/20303880-aprea-therapeutics-reports-third-quarter-2025-financial-results-and-provides-a-clinical] (APRE [https://seekingalpha.com/symbol/APRE]): Q3 GAAP EPS of -$0.47.
* Revenue of $1.84M.

MORE ON APREA THERAPEUTICS

* Seeking Alpha’s Quant Rating on Aprea Therapeutics [https://seekingalpha.com/symbol/APRE/ratings/quant-ratings]
* Historical earnings data for Aprea Therapeutics [https://seekingalpha.com/symbol/APRE/earnings]
* Financial information for Aprea Therapeutics [https://seekingalpha.com/symbol/APRE/income-statement]